Close
Novotech
Jabsco PureFlo 21 Single Use

News

Moderna to come up with combined Covid and flu booster by 2023

US drugmaker Moderna is working on a combined Covid-19 and flu booster shot, which could be available in some countries by fall 2023 at the earliest, CEO Stephane Bancel has said. In his speech at the Davos Agenda, a virtual...

Bormioli Pharma announces the winners of the open innovation contest launched in collaboration with Desall

Bormioli Pharma, an international leader in the production of glass and plastic containers for pharmaceutical use, announced the winners of the "Bormioli Pharma Dispenser Design" contest launched last summer on the open innovation & crowdsourcing platform Desall.com. The competition...

Lifesaving Technology: Expert Explains How to Efficiently Use Air-con in the Midst of Covid-19

In a time where we are surrounded by government guidelines and continually given advice by healthcare professionals, people and businesses have never been more conscious of their air conditioning and heating use. When used properly and efficiently, both air-con and heating can still...

Medlab receives grant to develop NanoCelle Nasal RNA vaccine for covid-19

Medlab Clinical Ltd is pleased to announce in collaboration with Prof Pall Thordarson (Director of the UNSW RNA Institute, UNSW) and Prof Daniela Traini (NHMRC Investigator, Biomedical Sciences, Macquarie University and The Woolcock Institute of Medical Research) received a...

WHO recommends two new drugs to treat COVID-19

WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be. The first drug, baricitinib, is...

Procaps Group Expands Global CDMO Business

Procaps Group, an integrated international healthcare and pharmaceutical company, announced the closing of an asset purchase agreement to acquire an 86,000 square foot pharmaceutical production facility located in West Palm Beach, FL with production capacity of approximately 1.8 billion...

Everest Medicines, Singapore’s EDDC Enter Global Licensing Agreement for COVID Oral Antivirals

Everest Medicines and Singapore's Experimental Drug Development Centre (EDDC) entered a global licensing agreement under which Everest will obtain exclusive worldwide rights to develop, manufacture and commercialize EDDC's series of viral 3C-like (3CL) protease inhibitors as potentially best-in-class COVID-19...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »